![IRIS International, Inc.](/news-release/logo/213967/0/213967.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A00&size=2)
IRIS International to Present NADiA ProsVue at Two Important Meetings in Washington DC Addressing the Role of Advanced Diagnostics in Cancer
September 20, 2012 08:00 ET
|
IRIS International, Inc.
CHATSWORTH, Calif., Sept. 20, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a provider of high...
![IRIS International, Inc.](/news-release/logo/213967/0/213967.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A00&size=2)
IRIS International Announces Agreement to be Acquired by Danaher Corporation for $19.50 per Share
September 17, 2012 08:22 ET
|
IRIS International, Inc.
CHATSWORTH, Calif., Sept. 17, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a provider of high...
![IRIS International, Inc.](/news-release/logo/213967/0/213967.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A00&size=2)
IRIS International Announces Second Quarter 2012 Revenue and Financial Results
July 31, 2012 16:05 ET
|
IRIS International, Inc.
Record revenue of $30.9 million in Q2 2012; 2% growth over Q2 2011
Gross margin of 54% in Q2 2012
GAAP EPS of $0.07 in Q2 2012
Reaffirming 2012 guidance of revenues in a range from...
![IRIS International, Inc.](/news-release/logo/213967/0/213967.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A00&size=2)
IRIS to Release Second Quarter Financial Results and Host Conference Call and Webcast on Tuesday, July 31
July 19, 2012 16:05 ET
|
IRIS International, Inc.
CHATSWORTH, Calif., July 19, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables and a provider of...
![IRIS International, Inc.](/news-release/logo/213967/0/213967.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A00&size=2)
IRIS International Announces Distribution Agreement With Alifax and Launch of ESR Automated Instrumentation
July 17, 2012 17:30 ET
|
IRIS International, Inc.
CHATSWORTH, Calif., July 17, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables and a provider of...
![IRIS International, Inc.](/news-release/logo/213967/0/213967.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A00&size=2)
IRIS International Announces Clinical Data Presentation of NADiA(R) ProsVue(TM) Benefits at the 5th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer
June 06, 2012 18:21 ET
|
IRIS International, Inc.
CHATSWORTH, Calif., June 6, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables and a provider of...
![IRIS International, Inc.](/news-release/logo/213967/0/213967.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A00&size=2)
IRIS International to Present at Upcoming Investor Conferences
May 25, 2012 10:41 ET
|
IRIS International, Inc.
CHATSWORTH, Calif., May 25, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables and a provider of...
![IRIS International, Inc.](/news-release/logo/213967/0/213967.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A00&size=2)
IRIS International Unveils NADiA(R) ProsVue(TM) at the American Urological Association (AUA) Annual Meeting, May 19-24, 2012
May 21, 2012 08:30 ET
|
IRIS International, Inc.
Test Identifies Patients at Reduced Risk for Prostate Cancer Clinical Recurrence After Surgery
CHATSWORTH, Calif., May 21, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a...
![IRIS International, Inc.](/news-release/logo/213967/0/213967.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A00&size=2)
IRIS International Announces First Quarter 2012 Revenue and Financial Results
May 02, 2012 16:05 ET
|
IRIS International, Inc.
Record revenue of $29.9 million in Q1 2012; 11% growth over Q1 2011
Gross margin of 53% in Q1 2012
GAAP EPS of $0.05 in Q1 2012
Reaffirming 2012 guidance of revenues in a range from...
![IRIS International, Inc.](/news-release/logo/213967/0/213967.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A00&size=2)
IRIS to Release First Quarter Financial Results and Host Conference Call and Webcast on Wednesday, May 2, 2012
April 13, 2012 16:10 ET
|
IRIS International, Inc.
CHATSWORTH, Calif., April 13, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a developer of...